Protein-Bound Uremic Toxins Quantification by a Colorimetric Sensor Based on the Oxidation of Silver Nanoparticles

被引:4
作者
Schiefer, Elberth M. [1 ]
Santos, Andressa F. [2 ]
Muller, Marcia [1 ]
Stinghen, Andrea E. M. [3 ]
Negri, Lucas H. [4 ]
Fabris, Jose L. [1 ]
机构
[1] Univ Tecnol Fed Parana, Grad Program Elect & Comp Engn, BR-80230901 Curitiba, Parana, Brazil
[2] Univ Tecnol Fed Parana, Nephrol Lab, Clin Anal Dept, BR-80060000 Curitiba, Parana, Brazil
[3] Univ Tecnol Fed Parana, Nephrol Lab, Basic Pathol Dept, BR-80060000 Curitiba, Parana, Brazil
[4] Inst Fed Educ Ciencia & Tecnol Mato Grosso Sul, BR-79750000 Nova Andradina, Brazil
关键词
Nanoparticles; Sensors; Silver; Proteins; Oxidation; Hydrogen; Temperature measurement; AgNPs; BSA; quantification; PBUTs; chronic kidney disease; CHRONIC KIDNEY-DISEASE; RAPID DETECTION; SIZE;
D O I
10.1109/JSEN.2021.3109567
中图分类号
TM [电工技术]; TN [电子技术、通信技术];
学科分类号
0808 ; 0809 ;
摘要
This work shows a colorimetric sensor based on albumin bound to citrate-capped silver nanoparticles. The sensor capability of detecting protein-bound uremic toxins, such as indoxyl sulfate and p-cresylsulfate, is demonstrated. These uremic toxins enhance the oxidation of citrate-capped silver nanoparticles by hydrogen peroxide, affecting the localized surface plasmon resonance and allowing the proposed colorimetric sensing method. The method exhibits a linear response for indoxyl sulfate and p-cresylsulfate concentrations ranging from 15 to 100 mg/L with resolutions of 0.56 mg/L and 0.41 mg/L and expanded uncertainties for a confidence level of 95% of 17.23 mg/L and 12.55 mg/L, respectively. Limits of detection and quantification of 5.7 mg/L and 19 mg/L for indoxyl sulfate and of 3.2 mg/L and 10.7 mg/L for p-cresylsulfate were obtained for p < 0.05. These characteristics of the colorimetric method allow for a distinction between total normal and total uremic blood concentrations, which reported levels are (0.54 +/- 4.00) mg/L and (37.07 +/- 26.50) mg/L for indoxyl sulfate and (1.87 +/- 2.31) mg/L and (23.00 +/- 16.90) mg/L for p-cresylsulfate. Besides, this novel sensor significantly reduces costs of analysis and facilitates the quantification of those toxins. The interaction between albumin and citrate-capped silver nanoparticles was also investigated by Raman spectroscopy.
引用
收藏
页码:22651 / 22660
页数:10
相关论文
共 43 条
[1]   A comparative and simultaneous analysis of indoxyl sulfate and sodium butyrate in human plasma by SPE and HPLC methods for kidney patients [J].
ALOthman, Zeid A. ;
ALanazi, Abdullah G. ;
Ali, Imran .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2020, 1159
[2]   Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study [J].
Amabile, Nicolas ;
Guerin, Alain P. ;
Tedgui, Alain ;
Boulanger, Chantal M. ;
London, Gerard M. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (05) :1873-1880
[3]  
[Anonymous], 2008, EVALUATION MEASUREME
[4]  
Barreto Fellype Carvalho, 2014, Braz. J. Nephrol., V36, P221, DOI 10.5935/0101-2800.20140033
[5]   Optical extinction spectroscopy of single silver nanoparticles [J].
Billaud, P. ;
Huntzinger, J.-R. ;
Cottancin, E. ;
Lerme, J. ;
Pellarin, M. ;
Arnaud, L. ;
Broyer, M. ;
Del Fatti, N. ;
Vallee, F. .
EUROPEAN PHYSICAL JOURNAL D, 2007, 43 (1-3) :271-274
[6]  
Bronze-Uhle ES, 2017, NANOTECHNOL SCI APPL, V10, P11, DOI 10.2147/NSA.S117018
[7]   Structures of bovine, equine and leporine serum albumin [J].
Bujacz, Anna .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2012, 68 :1278-1289
[8]   Uremic Toxins and their Relation to Dialysis Efficacy [J].
Clark, William R. ;
Dehghani, Nader Laal ;
Narsimhan, Vivek ;
Ronco, Claudio .
BLOOD PURIFICATION, 2019, 48 (04) :299-314
[9]   A sensitive HPLC method for the quantification of free and total p-cresol in patients with chronic renal failure [J].
De Smet, R ;
David, F ;
Sandra, P ;
Van Kaer, J ;
Lesaffer, G ;
Dhondt, A ;
Lameire, N ;
Vanholder, R .
CLINICA CHIMICA ACTA, 1998, 278 (01) :1-21
[10]  
Desimoni E., 2015, Pharmaceutica Analytica Acta, V6, P2153, DOI DOI 10.4172/2153-2435.1000355